Drug Shortage Report for DESVENLAFAXINE
Report ID | 231999 |
Drug Identification Number | 02535106 |
Brand name | DESVENLAFAXINE |
Common or Proper name | DESVENLAFAXINE |
Company Name | SANIS HEALTH INC |
Market Status | MARKETED |
Active Ingredient(s) | DESVENLAFAXINE |
Strength(s) | 50MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-08-30 |
Actual start date | 2024-08-28 |
Estimated end date | 2024-11-15 |
Actual end date | 2024-11-13 |
Shortage status | Resolved |
Updated date | 2024-11-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-11-14 | English | Compare |
v7 | 2024-11-13 | French | Compare |
v6 | 2024-11-13 | English | Compare |
v5 | 2024-08-29 | English | Compare |
v4 | 2024-08-28 | French | Compare |
v3 | 2024-08-28 | English | Compare |
v2 | 2024-07-03 | French | Compare |
v1 | 2024-07-03 | English | Compare |
Showing 1 to 8 of 8